Emerald Therapeutics, Inc. — Form D/A
Emerald Therapeutics, Inc. of MENLO PARK, CA, a company, filed a Form D amendment with the SEC on 2010-12-22. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2010-12-22
- Form: D/A
- Accession: 0001104659-10-063988
- Industry: Other Health Care
- Exemptions: 06
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 14
- Date of first sale: 2010-09-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-148205
Issuer
- Name: Emerald Therapeutics, Inc.
- CIK: 0001501852
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 3745-M EDISON WAY, MENLO PARK, CA, 94025
- Phone: 650-257-7554
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Max R Levchin | Director | San Francisco, CA |
| Daniel J Kleinbaum | Director | Menlo Park, CA |
| Daniel J Kleinbaum | Executive Officer | Menlo Park, CA |
| Brian R Singerman | Director | Menlo Park, CA |
| Brian J Frezza | Director | Menlo Park, CA |
| Brian J Frezza | Executive Officer | Menlo Park, CA |
| Brian Frezza | Director | Menlo Park, CA |
| Brian Frezza | Executive Officer | Menlo Park, CA |
| Luke R Nosek | Director | Menlo Park, CA |
| Luke J Nosek | Director | San Francisco, CA |
Other filings by this issuer (3)
More